Apr 30 2015
Research and Markets has announced the addition of the "European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type (Minimally Invasive, Non-Invasive), by End-User (Hospitals, Ambulatory Care, Others) - Forecast to 2019" report to their offering.
The non-invasive & minimally invasive cardiac output monitoring devices market is estimated to grow at a CAGR of 4.2% from 2014 to 2019.
Germany holds a larger share in the Europe non-invasive & minimally invasive cardiac output monitoring devices market around 35.2% in 2014 followed by France. Rest of Europe includes Netherlands, Sweden, Poland, Switzerland, Belgium and others. The Europe non-invasive & minimally invasive cardiac output monitoring devices market holds a high potential for growth in future due to a number of forces favoring this market. The Sedentary lifestyle, Technological advancements & remote monitoring of cardiac output and recommendations to use these devices by appropriate organizations/associations such as National Institute for Health and Care Excellence (NICE) are driving this market.
However, deflections from accuracy and reduced reliability under periods of hemodynamic instability hinder the growth of the market.
In this report, the non-invasive & minimally invasive cardiac output monitoring devices market is segmented on the basis of its technology and end-users. The revenue cycle management market, by technologies are pulse pressure analysis, doppler cardiac output monitoring devices, bioimpedance & bioreactance. The end-users are ambulatory care solutions and hospitals.
The report has profiled the leading players of this market along with the developments (New product launches and partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the Europe non-invasive & minimally invasive cardiac output monitoring devices market.